Every coffee keeps the site running. Thank you!
Tech, gaming and the news that matters
Unprecedented demand for anti-obesity medications has exposed severe capacity limitations across primary pharmaceutical manufacturing lines.
Scaling Bioprocessing
Contract development organisations are scaling continuous-flow peptide synthesis, aiming to double output yields while lowering batch processing times by mid-2025.
Biotechnology firms leverage machine learning models to streamline candidate drug selection and patient cohort matching.
Machine learning algorithms reducing candidate identification timelines by half, enabling faster transitions to Phase I human trials.
Clinical trial progressions demonstrate viable delivery mechanisms for gene editing treatments targeting monogenic disorders.
The surging demand for metabolic therapeutics is forcing major drugmakers to reprioritize capital from oncology and rare disease…
Hospital networks are scaling continuous biosensor monitoring to reduce hospital readmissions and manage chronic disease populations cost-effectively.
We all want to improve our lives and the circumstances we find ourselves present in. We need to…